Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Kotoku, Tokyo, 135-8551, Japan.
Gastric Cancer. 2018 May;21(3):516-523. doi: 10.1007/s10120-017-0776-8. Epub 2017 Nov 10.
BACKGROUND: Preserving the hepatic and pyloric branches of the vagal nerve in laparoscopic pylorus-preserving gastrectomy (LPPG) is considered necessary to maintain the function of the pyloric cuff. However, the clinical benefits of preservation of the celiac branch of the vagal nerve (CBVN) remain unclear. METHODS: Of 391 patients who underwent LPPG for early gastric cancer, 116 patients in whom the CBVN was preserved (CBP group) and 58 patients in whom it was not preserved (non-CBP group) were selected through the propensity score-matching method. To evaluate the surgical and oncological safety of preserving the CBVN, postoperative morbidity and mortality were analyzed between these matched groups. Postoperative nutritional status, body weight changes, endoscopic findings, and the incidence of gallstones were compared to evaluate any functional advantages. RESULTS: The short-term surgical outcomes in the CBP group were similar to those in the non-CBP group. The number of dissected lymph nodes did not differ (34 vs. 33.5, P = 0.457), and the 5-year recurrence-free survival rates were also similar between both groups (99.1% vs. 97.1%, P = 0.844). There were no significant differences in postoperative nutritional status, body weight changes, or the incidence of gallstones. By endoscopy, 1 year after surgery residual food was frequently observed in both groups; however, there were no significant differences in the frequency of remnant gastritis and esophageal and bile reflux. CONCLUSIONS: Preserving CBVN in LPPG for early gastric cancer is a feasible procedure. However, no clinical benefits of the preservation of the CBVN after LPPG are identified.
背景:腹腔镜保留幽门胃切除术(LPPG)中保留迷走神经肝支和幽门支被认为是维持幽门袖功能所必需的。然而,保留腹腔支迷走神经(CBVN)的临床获益尚不清楚。
方法:对 391 例早期胃癌行 LPPG 的患者,采用倾向性评分匹配法选择 116 例保留 CBVN 的患者(CBP 组)和 58 例未保留 CBVN 的患者(非 CBP 组)。为评估保留 CBVN 的手术和肿瘤学安全性,对这两组匹配患者的术后发病率和死亡率进行了分析。为评估任何功能优势,比较了术后营养状况、体重变化、内镜表现和胆结石的发生率。
结果:CBP 组的短期手术结果与非 CBP 组相似。淋巴结清扫数目无差异(34 与 33.5,P=0.457),两组 5 年无复发生存率也相似(99.1%与 97.1%,P=0.844)。术后营养状况、体重变化或胆结石发生率无显著差异。内镜检查显示,术后 1 年两组均有残留食物,但残胃炎、食管和胆汁反流的发生率无显著差异。
结论:在早期胃癌的 LPPG 中保留 CBVN 是可行的。然而,在 LPPG 后保留 CBVN 并没有明显的临床获益。
Langenbecks Arch Surg. 2017-2
Zhonghua Wei Chang Wai Ke Za Zhi. 2020-10-25
Ann Surg Oncol. 2023-4
Cancers (Basel). 2021-12-10
Ann Gastroenterol Surg. 2021-1-27
Transl Gastroenterol Hepatol. 2020-4-5
Ann Surg Oncol. 2013-3-16
Int J Cancer. 2013-3-4
Gastric Cancer. 2012-6-23
Hepatogastroenterology. 2012-9